Clinical trial NCT02459210 - References

Psychosis — Adaptation of Cognitive Enhancement Therapy for Persons at Clinical High Risk for Psychosis

Citation(s)

•   Addington J, Cadenhead KS, Cannon TD, Cornblatt B, McGlashan TH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Heinssen R; North American Prodrome Longitudinal Study
  North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull. 2007 May;33(3):665-72. Epub 2007 Jan 25.
•   Ben-Yishay Y, Piasetsky EB, Rattok J
  A systematic method for ameliorating disorders in basic attention. In: Meir MJ, Benton AL, Diller L, eds. Neuropsychological Rehabilitation. New York, NY: Guilford; 1985:165 181.
•   Bracy OL
  PSSCogRehab.Indianapolis, IN: Psychological Software Services Inc; 1994.
•   Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, Seidman LJ, Perkins D, Tsuang M, McGlashan T, Heinssen R
  Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry. 2008 Jan;65(1):28-37. doi: 10.1001/archgenpsychiatry.2007.3.
•   Cannon-Spoor HE, Potkin SG, Wyatt RJ
  Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull. 1982;8(3):470-84.
•   Carrión RE, McLaughlin D, Goldberg TE, Auther AM, Olsen RH, Olvet DM, Correll CU, Cornblatt BA
  Prediction of functional outcome in individuals at clinical high risk for psychosis. JAMA Psychiatry. 2013 Nov;70(11):1133-42. doi: 10.1001/jamapsychiatry.2013.1909.
•   Eack SM, Greeno CG, Pogue-Geile MF, Newhill CE, Hogarty GE, Keshavan MS
  Assessing social-cognitive deficits in schizophrenia with the Mayer-Salovey-Caruso Emotional Intelligence Test. Schizophr Bull. 2010 Mar;36(2):370-80. doi: 10.1093/schbul/sbn091. Epub 2008 Jul 22.
•   Eack SM, Greenwald DP, Hogarty SS, Cooley SJ, DiBarry AL, Montrose DM, Keshavan MS
  Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial. Psychiatr Serv. 2009 Nov;60(11):1468-76. doi: 10.1176/appi.ps.60.11.1468.
•   Eack SM, Greenwald DP, Hogarty SS, Keshavan MS
  One-year durability of the effects of cognitive enhancement therapy on functional outcome in early schizophrenia. Schizophr Res. 2010 Jul;120(1-3):210-6. doi: 10.1016/j.schres.2010.03.042. Epub 2010 May 15.
•   Eack SM, Hogarty GE, Cho RY, Prasad KM, Greenwald DP, Hogarty SS, Keshavan MS
  Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial. Arch Gen Psychiatry. 2010 Jul;67(7):674-82. doi: 10.1001/archgenpsychiatry.2010.63. Epub 2010 May 3.
•   Eack SM, Hogarty GE, Greenwald DP, Hogarty SS, Keshavan MS
  Cognitive enhancement therapy improves emotional intelligence in early course schizophrenia: preliminary effects. Schizophr Res. 2007 Jan;89(1-3):308-11. Epub 2006 Oct 19.
•   Eack SM, Hogarty GE, Greenwald DP, Hogarty SS, Keshavan MS
  Effects of Cognitive Enhancement Therapy on Employment Outcomes in Early Schizophrenia: Results From a Two-Year Randomized Trial. Res Soc Work Pract. 2011 Jan 27;21(1):32-42.
•   Fisher M, Loewy R, Hardy K, Schlosser D, Vinogradov S
  Cognitive interventions targeting brain plasticity in the prodromal and early phases of schizophrenia. Annu Rev Clin Psychol. 2013;9:435-63. doi: 10.1146/annurev-clinpsy-032511-143134. Epub 2013 Jan 7. Review.
•   Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-Rössler A, Schultze-Lutter F, Keshavan M, Wood S, Ruhrmann S, Seidman LJ, Valmaggia L, Cannon T, Velthorst E, De Haan L, Cornblatt B, Bonoldi I, Birchwood M, McGlashan T, Carpenter W, McGorry P, Klosterkötter J, McGuire P, Yung A
  The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry. 2013 Jan;70(1):107-20. doi: 10.1001/jamapsychiatry.2013.269. Review.
•   Giuliano AJ, Li H, Mesholam-Gately RI, Sorenson SM, Woodberry KA, Seidman LJ
  Neurocognition in the psychosis risk syndrome: a quantitative and qualitative review. Curr Pharm Des. 2012;18(4):399-415. Review.
•   Green MF, Hellemann G, Horan WP, Lee J, Wynn JK
  From perception to functional outcome in schizophrenia: modeling the role of ability and motivation. Arch Gen Psychiatry. 2012 Dec;69(12):1216-24. doi: 10.1001/archgenpsychiatry.2012.652.
•   Green MF, Kern RS, Braff DL, Mintz J
  Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull. 2000;26(1):119-36. Review.
•   Heinrichs RW, Zakzanis KK
  Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology. 1998 Jul;12(3):426-45.
•   Hogarty GE, Flesher S, Ulrich R, Carter M, Greenwald D, Pogue-Geile M, Kechavan M, Cooley S, DiBarry AL, Garrett A, Parepally H, Zoretich R
  Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior. Arch Gen Psychiatry. 2004 Sep;61(9):866-76.
•   Hogarty, G
  E., & Greenwald, D. P: Cognitive Enhancement Therapy: The Training Manual. University of Pittsburgh Medical Center: Authors. Available through www.CognitiveEnhancementTherapy.com, 2006.
•   Keshavan MS, DeLisi LE, Seidman LJ
  Early and broadly defined psychosis risk mental states. Schizophr Res. 2011 Mar;126(1-3):1-10. doi: 10.1016/j.schres.2010.10.006. Epub 2010 Nov 30.
•   Keshavan MS, Hogarty GE
  Brain maturational processes and delayed onset in schizophrenia. Dev Psychopathol. 1999 Summer;11(3):525-43. Review.
•   Kohler CG, Turner TH, Bilker WB, Brensinger CM, Siegel SJ, Kanes SJ, Gur RE, Gur RC
  Facial emotion recognition in schizophrenia: intensity effects and error pattern. Am J Psychiatry. 2003 Oct;160(10):1768-74.
•   Mayer JD, Salovey P, Caruso DR, Sitarenios G
  Measuring emotional intelligence with the MSCEIT V2.0. Emotion. 2003 Mar;3(1):97-105.
•   McDonald S, Bornhofen C, Shum D, Long E, Saunders C, Neulinger K
  Reliability and validity of The Awareness of Social Inference Test (TASIT): a clinical test of social perception. Disabil Rehabil. 2006 Dec 30;28(24):1529-42.
•   McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, Germano D, Bravin J, McDonald T, Blair A, Adlard S, Jackson H
  Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry. 2002 Oct;59(10):921-8.
•   Mesholam-Gately RI, Giuliano AJ, Goff KP, Faraone SV, Seidman LJ
  Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology. 2009 May;23(3):315-36. doi: 10.1037/a0014708. Review.
•   Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK
  Identification of separable cognitive factors in schizophrenia. Schizophr Res. 2004 Dec 15;72(1):29-39. Review.
•   Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, Essock S, Fenton WS, Frese FJ 3rd, Gold JM, Goldberg T, Heaton RK, Keefe RS, Kraemer H, Mesholam-Gately R, Seidman LJ, Stover E, Weinberger DR, Young AS, Zalcman S, Marder SR
  The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry. 2008 Feb;165(2):203-13. doi: 10.1176/appi.ajp.2007.07010042. Epub 2008 Jan 2.
•   Vinogradov S, Fisher M, de Villers-Sidani E
  Cognitive training for impaired neural systems in neuropsychiatric illness. Neuropsychopharmacology. 2012 Jan;37(1):43-76. doi: 10.1038/npp.2011.251. Epub 2011 Nov 2. Review.
•   Waber DP, Holmes JM
  Assessing children's copy productions of the Rey-Osterrieth Complex Figure. J Clin Exp Neuropsychol. 1985 Jun;7(3):264-80.
•   Wood SJ, Yung AR, McGorry PD, Pantelis C
  Neuroimaging and treatment evidence for clinical staging in psychotic disorders: from the at-risk mental state to chronic schizophrenia. Biol Psychiatry. 2011 Oct 1;70(7):619-25. doi: 10.1016/j.biopsych.2011.05.034. Epub 2011 Jul 18. Review.
•   Woodberry KA, Giuliano AJ, Seidman LJ
  Premorbid IQ in schizophrenia: a meta-analytic review. Am J Psychiatry. 2008 May;165(5):579-87. doi: 10.1176/appi.ajp.2008.07081242. Epub 2008 Apr 15.
•   Wykes T, Huddy V, Cellard C, McGurk SR, Czobor P
  A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry. 2011 May;168(5):472-85. doi: 10.1176/appi.ajp.2010.10060855. Epub 2011 Mar 15.

CLUES (Cognition for Learning and for Understanding Everyday Social Situations): An Adaptation of Cognitive Enhancement Therapy for Persons at Clinical High Risk for Psychosis

Details for clinical trial NCT02459210